A recent report published in Health Affairs attributes rising costs of prescription drugs on price increases, not new, high-cost treatments, NPR reports.
The study found brand oral prescriptions more than 9 percent annually between 2008 and 2016, with the annual cost of injectables rising more than 15 percent.
“The main takeaway of our study should be that the increases in prices of brand-name drugs were largely driven by year-over-year price increases of drugs that were already in the market,” University of Pittsburg’s Immaculata Hernandez, the study’s lead author, said.
According to the report, insulin prices doubled between 2012-2016. Sanofi’s Lantus posted a 49 percent increase in 2014 alone, the University of Pittsburgh reports.
To read the full report on NPR, click here.